Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea
· Delayed Price · Currency is KRW 8,510.00
-140.00 (-1.62%)
At close: Apr 29, 2026
Kwang Dong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 317,105 | 230,184 | 218,039 | 297,799 | 244,840 | 305,229 | Upgrade
|
| Market Cap Growth | 50.05% | 5.57% | -26.78% | 21.63% | -19.79% | -27.51% | Upgrade
|
| Enterprise Value | 448,841 | 343,552 | 335,136 | 283,794 | 196,173 | 300,829 | Upgrade
|
| Last Close Price | 8650.00 | 5792.49 | 5278.48 | 7209.39 | 5705.21 | 6995.77 | Upgrade
|
| PE Ratio | 16.60 | 10.98 | 5.39 | 8.06 | 10.13 | 12.71 | Upgrade
|
| Forward PE | - | 14.32 | 14.32 | 14.32 | 14.32 | 14.32 | Upgrade
|
| PS Ratio | 0.19 | 0.14 | 0.13 | 0.20 | 0.17 | 0.23 | Upgrade
|
| PB Ratio | 0.45 | 0.32 | 0.35 | 0.51 | 0.45 | 0.58 | Upgrade
|
| P/TBV Ratio | 0.52 | 0.38 | 0.40 | 0.59 | 0.49 | 0.63 | Upgrade
|
| P/FCF Ratio | 6.04 | 4.39 | - | - | 6.54 | 9.80 | Upgrade
|
| P/OCF Ratio | 3.85 | 2.80 | - | - | 3.90 | 5.56 | Upgrade
|
| EV/Sales Ratio | 0.27 | 0.21 | 0.20 | 0.19 | 0.14 | 0.23 | Upgrade
|
| EV/EBITDA Ratio | 11.92 | 7.00 | 7.51 | 5.16 | 3.75 | 5.10 | Upgrade
|
| EV/EBIT Ratio | 22.89 | 11.07 | 11.14 | 6.75 | 5.13 | 6.70 | Upgrade
|
| EV/FCF Ratio | 8.55 | 6.55 | - | - | 5.24 | 9.66 | Upgrade
|
| Debt / Equity Ratio | 0.43 | 0.43 | 0.46 | 0.40 | 0.25 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 6.18 | 6.18 | 6.41 | 4.29 | 2.64 | 2.24 | Upgrade
|
| Debt / FCF Ratio | 5.78 | 5.78 | - | - | 3.69 | 4.24 | Upgrade
|
| Net Debt / Equity Ratio | 0.11 | 0.11 | 0.20 | 0.05 | -0.13 | -0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.54 | 1.54 | 2.70 | 0.54 | -1.35 | -0.94 | Upgrade
|
| Net Debt / FCF Ratio | 1.44 | 1.44 | -1.37 | -0.63 | -1.89 | -1.79 | Upgrade
|
| Asset Turnover | 1.33 | 1.33 | 1.46 | 1.51 | 1.58 | 1.56 | Upgrade
|
| Inventory Turnover | 6.47 | 6.47 | 6.62 | 6.95 | 7.34 | 6.58 | Upgrade
|
| Quick Ratio | 0.97 | 0.97 | 0.95 | 1.03 | 1.23 | 1.32 | Upgrade
|
| Current Ratio | 1.37 | 1.37 | 1.55 | 1.46 | 1.71 | 1.81 | Upgrade
|
| Return on Equity (ROE) | 3.21% | 3.21% | 6.94% | 6.94% | 4.97% | 4.96% | Upgrade
|
| Return on Assets (ROA) | 1.56% | 1.56% | 1.67% | 2.62% | 2.63% | 3.28% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.86% | 2.80% | 3.24% | 6.18% | 5.94% | 7.16% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.90% | 3.90% | 4.20% | 6.80% | 6.60% | 8.00% | Upgrade
|
| Earnings Yield | 6.61% | 9.11% | 18.57% | 12.41% | 9.87% | 7.87% | Upgrade
|
| FCF Yield | 16.55% | 22.80% | -40.31% | -15.62% | 15.29% | 10.20% | Upgrade
|
| Dividend Yield | 1.18% | - | - | - | 1.75% | 1.43% | Upgrade
|
| Payout Ratio | 18.73% | 18.73% | 9.90% | 11.11% | 16.99% | 17.10% | Upgrade
|
| Buyback Yield / Dilution | -0.52% | -0.52% | 1.06% | 1.48% | 0.11% | -1.48% | Upgrade
|
| Total Shareholder Return | 0.67% | -0.52% | 1.06% | 1.48% | 1.87% | -0.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.